What are the next steps after prescribing acyclovir (antiviral medication) 400 mg three times a day (TDS) for 5 days for shingles and ordering an HIV test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Steps After Prescribing Acyclovir 400mg TDS for Shingles

Critical Issue: Your Dosing is Incorrect and Inadequate

You need to immediately correct the acyclovir dose to 800mg five times daily (every 4 hours while awake) and extend the duration to 7-10 days, continuing until all lesions have completely scabbed. 1, 2

Why Your Current Prescription is Wrong:

  • The FDA-approved dose for herpes zoster is 800mg orally every 4 hours, 5 times daily for 7-10 days 2
  • Your prescribed dose of 400mg TDS (three times daily) is only appropriate for genital herpes or HSV suppression in HIV patients, not for shingles 3, 2
  • Research demonstrates that 800mg five times daily is superior to 400mg five times daily for herpes zoster, with the lower dose showing no significant benefit over placebo 4

Immediate Action Required

Contact the patient immediately to correct the prescription:

  • Change to: Acyclovir 800mg orally 5 times daily (every 4 hours while awake) for 7-10 days 1, 2
  • Continue treatment until ALL lesions have completely scabbed, not just for an arbitrary 5-7 days 1
  • Treatment is most effective when started within 72 hours of rash onset, ideally within 48 hours 1

Monitoring and Follow-Up

Clinical monitoring endpoints:

  • Assess for complete scabbing of all lesions - this is your treatment endpoint, not calendar days 1
  • Monitor for signs of dissemination (multi-dermatomal involvement, visceral symptoms) which would require IV acyclovir 1
  • Watch for complications including postherpetic neuralgia, ophthalmic involvement, or CNS symptoms 1

If the patient is immunocompromised or HIV-positive:

  • Consider IV acyclovir 10mg/kg every 8 hours instead of oral therapy 1
  • Higher oral doses (up to 800mg 5-6 times daily) may be needed 3, 5
  • Temporarily reduce immunosuppressive medications if applicable 1

Regarding the HIV Test

The HIV test you ordered is appropriate because:

  • Herpes zoster in younger patients or with severe/atypical presentation may indicate underlying immunosuppression 3, 1
  • HIV-infected patients with herpes zoster may require higher doses or IV therapy 3, 5
  • If HIV-positive, the patient may benefit from long-term acyclovir prophylaxis (400mg 2-3 times daily) 3, 5

Follow-up on HIV results:

  • If positive: Consider increasing acyclovir dose to 400mg 3-5 times daily until clinical resolution 3
  • If positive with severe disease: Switch to IV acyclovir 3
  • Monitor for acyclovir resistance if lesions persist despite treatment 3

Infection Control Counseling

Advise the patient:

  • Avoid contact with pregnant women, immunocompromised individuals, and those who haven't had chickenpox until all lesions are crusted 1
  • Lesions are contagious and can transmit varicella to susceptible individuals 1

Prevention for Future

After recovery, recommend:

  • Recombinant zoster vaccine (Shingrix) for adults ≥50 years, regardless of this episode 1
  • Vaccination should occur after complete healing 1

Common Pitfall You Made

The most critical error here is underdosing - 400mg TDS is approximately half the required dose for shingles and will likely result in treatment failure, prolonged symptoms, and increased risk of postherpetic neuralgia 2, 4. This is a common mistake when providers confuse HSV dosing with VZV dosing.

References

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapy of herpes zoster with oral acyclovir.

The American journal of medicine, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.